JG
BLFS icon

Joel Greenblatt’s BioLife Solutions BLFS Stock Holding History

Joel Greenblatt’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,812
Closed -$761K – 1732
2025
Q3 		$761K Sell
29,812
-9,811
-25% -$233K ﹤0.01% 1283
2025
Q2 		$853K Buy
+39,623
New +$893K 0.01% 1181
2025
Q1 		– Sell
-13,800
Closed -$358K – 1556
2024
Q4 		$358K Buy
13,800
+1,426
+12% +$35.5K ﹤0.01% 1219
2024
Q3 		$310K Buy
+12,374
New +$292K ﹤0.01% 1212

Other funds holding BLFS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Joel Greenblatt's BLFS Position: Q4 2025 in Review

Joel Greenblatt sold out of BioLife Solutions (BLFS) in Q4 2025, closing a stake of 29,812 shares — an estimated $761K sold.

Joel Greenblatt first reported a position in BLFS in Q3 2024 and held it in 4 quarters. The position peaked at $853K in Q2 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • Joel Greenblatt reported no remaining BioLife Solutions position as of Q4 2025 after selling out during the quarter.
  • Joel Greenblatt sold 29,812 BioLife Solutions shares in Q4 2025, an estimated $761K.
  • Joel Greenblatt first reported a position in BioLife Solutions in Q3 2024 and held it in 4 quarters.
  • Joel Greenblatt's BioLife Solutions position peaked at $853K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Gotham Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.